Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipids and cardiovascular diseases].

Z Reiner1

  • 1Zavoda za patolosku fiziologiju, KBC Rebro, Zagreb.

Lijecnicki Vjesnik
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

High cholesterol levels, a form of hyperlipoproteinemia, are linked to coronary heart disease. Lowering blood cholesterol through diet or medication can reduce heart disease risk and severity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke.

Gene·2020
Same author

Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.

Atherosclerosis·2016
Same author

Alirocumab: targeting PCSK9 to treat hypercholesterolemia.

Drugs of today (Barcelona, Spain : 1998)·2016
Same author

Resistance and intolerance to statins.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
Same author

SURF - SUrvey of Risk Factor management: first report of an international audit.

European journal of preventive cardiology·2012
Same journal

[Satisfaction of young doctors in Croatia: are we heading in the right direction?}.

Lijecnicki vjesnik·2018
Same journal

[Empa-reg and leader trials -revolution in modern diabetology?].

Lijecnicki vjesnik·2018
Same journal

[AUTONOMIC DYSREFLEXIA].

Lijecnicki vjesnik·2018
Same journal

[ASSESSMENT OF QUALITY OF LIFE IN GLAUCOMA PATIENTS].

Lijecnicki vjesnik·2018
Same journal

[HBsAg SEROCONVERSION IN THE TREATMENT OF CHRONIC HEPATITIS B WITH PEGYLATED INTERFERON].

Lijecnicki vjesnik·2018
Same journal

[FEMUR FRACTURES IN CHILDREN – CAUSES AND MECHANISMS OF INJURY].

Lijecnicki vjesnik·2018
See all related articles

Area of Science:

  • Biochemistry
  • Cardiology
  • Metabolic Disorders

Context:

  • Hyperlipoproteinemia, especially hypercholesterolemia, is strongly associated with coronary heart disease (CHD).
  • Atherosclerosis, the underlying cause of CHD, is intricately linked to lipid metabolism.
  • Understanding these connections is crucial for cardiovascular health management.

Purpose:

  • To provide an updated review of lipoprotein metabolism.
  • To elucidate the biochemical basis of atherogenic hyperlipoproteinemia.
  • To present current concepts on the etiology and pathogenesis of atherosclerosis.

Summary:

  • This review details lipoprotein metabolism and the biochemical underpinnings of atherogenic hyperlipoproteinemia.
  • It examines the extent to which reducing blood cholesterol impacts CHD prevalence and severity.

Related Experiment Videos

  • Guidance is provided on initiating dietary or drug treatment based on blood cholesterol levels.

    • Impact:

    • Informs clinical decisions regarding cholesterol management for reducing CHD risk.
    • Offers comprehensive insights into dietary and pharmacological interventions for hyperlipoproteinemia.
    • Provides a detailed overview of hypolipidemic agents, including dosages and adverse effects.